Disparities in screening and diagnosis for triple negative breast cancer
Gilead Sciences asked Charles River Associates and Tigerlily Foundation to examine the extent to which policies associated with triple negative breast cancer...
Industries
Life Sciences
We bring clarity to complex challenges.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
Our Focus Areas
Engagements
- 01CRA opines on irreparable harm at Delaware Chancery CourtIn a matter before the Delaware Chancery Court, CRA was retained by an early-stage pharmaceutical manufacturer whose trade secrets had been misappropriated...View engagement
- 02Transfer pricing planning for the impacts of COVID-19CRA was engaged by a global medical equipment company to analyze, help implement and defend the cross-border allocation of financial and tax impacts of the...View engagement
- 03CRA addressed a claim that a company had improperly failed to pay required development milestones upon termination of a drug development programIn litigation before the Delaware Court of Chancery, a CRA expert was asked to address the basis for a company’s decision to terminate the development of a...View engagement
Contact a Life Sciences expert.
See all Life Sciences expertsUpcoming Events
World Orphan Drug Congress Europe
Looking back 10 years, the rare disease space has significantly evolved with a plethora of innovative orphan drug launches and many patients gaining access to...
EFPIA Pandemic Prevention: how Europe can lead the fight against AMR
Tim Wilsdon is speaking during the session. For more information on this event, click here.
Recent Events
Roundtable Discussion: COVID-19 Impact on MedTech
The COVID-19 pandemic has had a significant impact – both positive and negative – on MedTech customers as well as the MedTech industry itself. Similar to how...
Living with SMA: Spotlight on the Policy and Access Environment in Europe
Steve Kelly and the other panelists discuss their paper titled “Assessing the policy and access environment across European countries for SMA patients.” For...